Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The 78th American Academy of Neurology (AAN) Annual Meeting took place in Chicago, IL, and online, from 18-22 April, 2026. This meeting brought together the global neurology community to share education and advances across all major neurology disciplines.
View all videos

AAN 2026

The 78th American Academy of Neurology (AAN) Annual Meeting
18–22 April 2026 | Chicago, IL & Online

AAN 2026

The 78th American Academy of Neurology (AAN) Annual Meeting
18–22 April 2026 | Chicago, IL & Online
The 78th American Academy of Neurology (AAN) Annual Meeting took place in Chicago, IL, and online, from 18-22 April, 2026. This meeting brought together the global neurology community to share education and advances across all major neurology disciplines.
View all videos

Highlights

View all
5:24
Efficacy and safety of ecopipam for Tourette syndrome: results from a Phase III trial
Kinga Tomczak • 21 Apr 2026
2:59
AMT-130 Huntington’s disease gene therapy: three-year Phase I/II trial outcomes
Victor Sung • 20 Apr 2026
2:30
Phase III HERCULES & GEMINI trials: tolebrutinib reduces disability progression in MS
Celia Oreja-Guevara • 21 Apr 2026
7:00
Orexin agonists and the future of narcolepsy treatment
Emmanuel Mignot • 30 Apr 2026
3:29
Updates on gene therapy-based approaches for the treatment of ALS
Defne Amado • 20 Apr 2026
1:55
NRTX-1001 restores inhibitory signaling in temporal lobe epilepsy
Peter Warnke • 29 Apr 2026
4:35
The unique characteristics of early-onset PD and the impact of autonomic dysfunction
Rodolfo Savica • 20 Apr 2026
5:52
Headache clinical trial highlights from AAN 2026
Peter Goadsby • 30 Apr 2026

Sleep Disorders

View all
2:08
Significant improvement in wakefulness with E2086 for narcolepsy: findings from a Phase I trial
Bruce Corser • 20 Apr 2026
1:05
The clinical potential of orexin-2 receptor agonists across sleep disorders
Bruce Corser • 20 Apr 2026

Movement Disorders

View all
1:57
Wearable devices for the management of essential tremor: FDA approval of the Encora X1 device
Jill Farmer • 21 Apr 2026
2:17
Guidance for the treatment of autonomic dysfunction in patients with movement disorders
Mitchell Miglis • 20 Apr 2026

Multiple Sclerosis & Related Disorders

View all
2:42
The role of BTK in MS pathophysiology and developments in BTK-targeting therapies
Augusto Miravalle • 21 Apr 2026
4:05
Aerobic training and its potential impact on neurogenesis in progressive multiple sclerosis
Tetsu Morozumi • 29 Apr 2026

Epilepsy

View all
1:47
Differentiating between seizure, stroke, and migraine
Noah Rosen • 19 Apr 2026
2:57
Advances in understanding and treating Sunflower syndrome, a rare photosensitive epilepsy
Elizabeth Thiele • 20 Apr 2026

Stroke

View all
1:47
Differentiating between seizure, stroke, and migraine
Noah Rosen • 19 Apr 2026
1:46
How will factor XIa inhibitors impact the future of secondary stroke prevention?
Mike Sharma • 9 Apr 2026

Headache

View all
2:29
Could a subset of sacral Tarlov cysts be misdiagnosed chronic sacral CSF leaks?
Andrew Callen • 21 Apr 2026
4:18
The gut-brain axis in the pathophysiology of pediatric migraine
Sara Pavitt • 30 Apr 2026

Neuromuscular Disorders

View all
2:28
The current understanding of ALS pathophysiology and its underlying causes
Defne Amado • 20 Apr 2026
3:29
Updates on gene therapy-based approaches for the treatment of ALS
Defne Amado • 20 Apr 2026
The content of VJNeurology is intended for healthcare professionals